首页> 外文期刊>The Journal of toxicological sciences >Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside
【24h】

Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside

机译:用庆大霉素,顺铂和嘌呤霉素氨基核苷的鱼糜猴尿毒性尿毒性尿毒性的有用性

获取原文
获取原文并翻译 | 示例
       

摘要

The objective of this study was to investigate the availability of novel urinary biomarkers (BMs) such as total protein, albumin, beta(2)-microglobulin, clusterin, cystatin C, neutrophil gelatinase-associated lipocalin (NGAL) for the detection of acute nephrotoxicity in cynomolgus monkeys. Animals (total 9 males/3 groups) were administered gentamicin (GM) subcutaneously at 40 mg/kg for 7 days, cisplatin (CDDP) intravenously at 3 mg/kg once and puromycin aminonucleoside (PAN) intravenously at 20 mg/kg for 7 days. Two-hr urine on Days 0, 3, and 6, and 16-hr urine and blood on Days 1, 4, and 7 were collected. Novel urinary BMs and conventional clinical pathology parameters were evaluated in parallel to histopathological and electron microscopic examinations on the kidneys at termination. Urinary BMs and enzymes increased earlier than serum creatinine and blood urea nitrogen, particularly in 2-hr urine after dosing on Day 0, urinary albumin was increased in all groups and urinary NGAL with the highest magnitude of change rate among urinary BMs was observed in the GM and CDDP groups. Degeneration/necrosis and hyaline droplet of renal tubule, cellular cast and dilatation of renal tubule, and hypertrophy of podocytes were observed in the GEN, CDDP, and PAN groups, respectively. These results showed that the increases of urinary BMs reflected the agent-specific renal damages and these urinary BMs could be useful for the detection of segment-specific nephrotoxicity. Urinary albumin and NGAL are the most useful BMs to estimate glomerular and distal tubular damages, respectively, as well as proximal tubular damage in cynomolgus monkeys.
机译:本研究的目的是探讨新型尿生物标志物(BMS)的可用性,例如总蛋白,白蛋白,β(2)-microgloblobulin,Clusterin,胱抑素C,中性粒细胞明胶酶相关的脂素(Ngal),用于检测急性肾毒性在cynomolgus猴子。将动物(总共9种Males / 3组)皮下给予庆大霉素(GM)在40mg / kg的40mg / kg,顺铂(CDDP),在3mg / kg一次和嘌呤霉素氨基核苷(PAN)以20mg / kg静脉注射7天。收集第0,3和6天,3和6天和16天尿液和血液的两性尿液。与终止肾脏的肾脏组织病理学和电子显微镜检查平行评估新型尿BMS和常规临床病理学参数。尿BMS和酶早期比血清肌酐和血尿尿素氮,特别是在第0天给药后的2-HR尿液中,在所有基团中增加尿白蛋白,并观察到泌尿育部BMS之间的最高变化率的尿NGAL。通用汽车和CDDP组。在Gen,CDDP和PAN组中,观察到肾小管的退化/坏死和肾小管肾小管扩张,肾小管的肥大,并且在泛群中观察到。这些结果表明,泌尿力学BMS的增加反映了药剂特异性肾脏损伤,这些泌尿力学BMS可用于检测分段特异性肾毒性。尿白蛋白和Ngal分别是最有用的BMS,以分别估计肾小球和远端管状损伤,以及在猴猴猴中的近端管状损伤。

著录项

  • 来源
  • 作者单位

    Shin Nippon Biomed Labs Ltd Drug Safety Res Labs 2438 Miyanoura Kagoshima 8911394 Japan;

    Shin Nippon Biomed Labs Ltd Drug Safety Res Labs 2438 Miyanoura Kagoshima 8911394 Japan;

    Shin Nippon Biomed Labs Ltd Drug Safety Res Labs 2438 Miyanoura Kagoshima 8911394 Japan;

    Shin Nippon Biomed Labs Ltd Drug Safety Res Labs 2438 Miyanoura Kagoshima 8911394 Japan;

    Shin Nippon Biomed Labs Ltd Drug Safety Res Labs 2438 Miyanoura Kagoshima 8911394 Japan;

    Shin Nippon Biomed Labs Ltd Drug Safety Res Labs 2438 Miyanoura Kagoshima 8911394 Japan;

    Shin Nippon Biomed Labs Ltd Drug Safety Res Labs 2438 Miyanoura Kagoshima 8911394 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

    Urinary biomarker; Nephrotoxicity; Cynomolgus monkeys;

    机译:尿生物标志物;肾毒性;鱼鹰猴;
  • 入库时间 2022-08-20 07:21:22

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号